Sequential Management with Gonadotropin-Releasing Hormone Agonist and Dienogest of Endometriosis-Associated Uterine Myoma and Adenomyosis

Abstract

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (24)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1 mg estradiol valerate/2 mg dienogest on hot flushes in postmenopausal women via openalex
• A rare case of de novo gigantic ovarian abscess within an endometrioma. via openalex
• Coexistence of endometriosis in women with symptomatic leiomyomas via openalex
• Dienogest: A New Therapeutic Agent for the Treatment of Endometriosis via openalex
• Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
• Endometrioma Complicated by Tubo‐Ovarian Abscess in a Woman With Bacterial Vaginosis via openalex
• High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
• New progestagens for contraceptive use via openalex
• W2154693051 via openalex
• W2162130706 via openalex
• W4233426577 via openalex
• W1658784312 via openalex
• W1964793478 via openalex
• W1972292493 via openalex
• W2013397751 via openalex
• W2023365171 via openalex
• W2041524060 via openalex
• W2045458073 via openalex
• W2073744849 via openalex
• W2101417341 via openalex
• W2129134761 via openalex

Cited by (1)

• Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study 2015

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00